Mayo Clinic Laboratories > Hematology > Lymphoid neoplasms > Chronic lymphocytic leukemia

Chronic lymphocytic leukemia

Testing for prognosis and risk stratification

Our approach to chronic lymphocytic leukemia testing meets all testing recommendations — including molecular testing for IGHV and TP53 mutations — as well as comprehensive fluorescence in situ hybridization (FISH) panels, which detect for genetic biomarkers associated with disease severity, progression, and treatment response. Because all testing is performed at one facility, the need for splitting patient samples is reduced, and continuity of care is increased.

Chronic lymphocytic leukemia Test menu

Chronic lymphocytic leukemia

Key testing



Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.